The hypothesis that the overproduction of SAA can cause systemic amyloidosis, i.e., amyloid deposits in various organs that promote thrombosis, together with our findings described above, led us to explore further the possible role of SAA in COVID-19-associated increased adhesion [28,29]. This evidence concerns the gene SAA2 and primary systemic amyloidosis.